Augmented antinociception following 7-nitro indazole and flurbiprofen in the conscious mouse
Co-administration of the nitric oxide synthase inhibitor, 7-nitro indazole (1 mg/kg i.[.), with the cyclooxygenase inhibitor, flurbiprofen (5–75 mg/kg i.p.), resulted in significantly enhanced antinociceptive activity in mice (formalin-induced hindpaw licking assay) without affecting hindpaw inflamm...
Saved in:
Published in | European journal of pharmacology Vol. 271; no. 2; pp. 445 - 452 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
27.12.1994
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Co-administration of the nitric oxide synthase inhibitor, 7-nitro indazole (1 mg/kg i.[.), with the cyclooxygenase inhibitor, flurbiprofen (5–75 mg/kg i.p.), resulted in significantly enhanced antinociceptive activity in mice (formalin-induced hindpaw licking assay) without affecting hindpaw inflammation. No antinociception was observed in animals pretreated with 7-nitro indazole (1 mg/kg i.p.) and flurbiprofen (100 μg subplantar). Flurbiprofen (50 mg/kg i.p.) pretreatment did not influence the inhibition of cerebellar or spinal cord nitric oxide synthase activity observed after 7-nitro indazole (1 or 25 mg/kg i.p.) administration and did not alter blood pressure in anaesthetised animals. Thus, flurbiprofen acts by a mechanism unrelated to a local anti-inflammatory effect in the hindpaw. Since nitric oxide synthase inhibitors are antinociceptive by an effect in the spinal cord (dorsal horn) this would appear to be a likely location for the nitric oxide synthase and cyclooxygenase enzymes targetted by 7-nitro indazole and flurbiprofen respectively. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0014-2999 1879-0712 |
DOI: | 10.1016/0014-2999(94)90805-2 |